Abstract
BackgroundLocal recurrence remains the principal oncological concern after segmentectomy. We examined its incidence, and where residual risk persists, in a cohort managed under a standardized technical framework of routine three-dimensional planning, selective preoperative tumor localization and intersegmental plane demarcation.Patients and MethodsWe retrospectively studied 517 consecutive patients who underwent anatomical segmentectomy for clinical stage I non-small-cell lung cancer at a single center between January 2011 and August 2022. All resections included individual division of the segmental artery and bronchus. Local recurrence was defined as relapse at or adjacent to the intersegmental staple line, and its cumulative incidence was estimated by the Kaplan-Meier method. Associations were tested with Mann-Whitney U and Fisher exact tests.ResultsOver a median follow-up of 63 months (interquartile range 50-91.5), local recurrence occurred in 10 patients, with a 5-year cumulative incidence of 1.7% (95% confidence interval 0.5-2.9). Consolidation size, consolidation-to-tumor ratio, central location (each P = 0.01) and a compromised indication (P = 0.03) were associated with local recurrence. Recurrence was concentrated in solid-dominant tumors resected for compromised indications (6 of 102, 5.9%) compared with all other strata (4 of 415, 1.0%; P = 0.005). Rates did not differ across the three demarcation techniques (P = 1.00) or by localization (P = 0.51).ConclusionUnder a standardized technical framework, local recurrence after segmentectomy was infrequent, but residual risk was concentrated almost entirely in solid-dominant tumors resected for compromised indications, in whom a wider parenchymal margin or extension to an adjacent segment should be considered.